Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/24/2015 03/25/2015 03/26/2015 03/27/2015 03/30/2015 Date
9.56(c) 8.99(c) 9.15(c) 9.26(c) 9.34(c) Last
411 898 1 906 225 4 129 692 717 683 466 123 Volume
-0.73% -5.96% +1.78% +1.20% +0.86% Change
More quotes
Financials ($)
Sales 2015 103 M
EBIT 2015 -40,3 M
Net income 2015 -42,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 148 M
EBIT 2016 -14,5 M
Net income 2016 -22,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,76x
Capi. / Sales 2016 2,62x
Capitalization 389 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
03/20 VANDA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
03/11 VANDA PHARMACEUTICALS : Announces Tradipitant Phase II Proof of Concept Study Re..
03/06 VANDA PHARMACEUTICALS : declares Tradipitant Phase II Proof of Concept study res..
03/05 VANDA PHARMACEUTICALS : VNDA) is Trading Lower on Unusual Volume for March 05
03/04 VANDA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
03/04 VANDA PHARMACEUTICALS : Announces Tradipitant Phase II Proof of Concept Study Re..
02/25 VANDA PHARMACEUTICALS : Reports Fourth Quarter 2014 and Full Year 2014 Financial..
02/19 VANDA PHARMACEUTICALS : posts 4Q profit
More news
Sector news : Bio Therapeutic Drugs
03/30 PUMA BIOTECHNOLOGY : NYSE stocks posting largest percentage increases
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/05 Vanda Pharmaceuticals' Pipeline Goes Up In Smoke
03/04 After Hours Gainers / Losers
02/25 Vanda Pharmaceuticals May Not Make Sales Expectations
02/19 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q4 2014 Results - ..
02/19 Vanda Pharmaceuticals (VNDA) Q4 2014 Results - Earnings Call Webcast


Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF